Association of rs6259 polymorphism with SHBG levels and Poly Cystic Ovary Syndrome in Indian population: a case control study
Abstract Polycystic ovary syndrome (PCOS) is the most common endocrinopathy of reproductive-aged women. PCOS reflects a number of possible etiologies but its pathophysiology is still unclear. The principal abnormality of the syndrome is hyperandrogenism (70–80%). The access of androgens to target tissues is regulated by sex hormone-binding globulin (SHBG), a transport protein secreted by liver i.e. specific for androgens. Present study was done to find the association of rs6259 polymorphism with SHBG levels and Poly Cystic Ovary Syndrome in Indian population. Present study was a case control study. 400 subjects were enrolled for the study and serum SHBG levels and D327N polymorphism were measured. The D327N polymorphism (wild-type and variant allele) was detected using PCR-RFLP method (restriction enzyme Bbs-I). PCOS group was found to have significantly lower SHBG levels than healthy controls. There was no significant difference in genotype distribution between PCOS and controls ($ χ^{2} $ = 1.0335, p = 0.59). Significant difference in SHBG levels of PCOS and control group highlights the potential of SHBG as a biomarker for PCOS. However, no significant difference in genotype distribution between PCOS and controls provided an insight that rs6259 polymorphism is not associated with the risk of PCOS and SHBG levels..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
Molecular biology reports - 46(2019), 2 vom: 04. Feb., Seite 2131-2138 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bhatnager, Richa [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
| doi: |
10.1007/s11033-019-04665-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR015920291 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR015920291 | ||
| 003 | DE-627 | ||
| 005 | 20230520004534.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201006s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11033-019-04665-2 |2 doi | |
| 035 | |a (DE-627)SPR015920291 | ||
| 035 | |a (SPR)s11033-019-04665-2-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q ASE |
| 084 | |a 42.13 |2 bkl | ||
| 100 | 1 | |a Bhatnager, Richa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Association of rs6259 polymorphism with SHBG levels and Poly Cystic Ovary Syndrome in Indian population: a case control study |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Polycystic ovary syndrome (PCOS) is the most common endocrinopathy of reproductive-aged women. PCOS reflects a number of possible etiologies but its pathophysiology is still unclear. The principal abnormality of the syndrome is hyperandrogenism (70–80%). The access of androgens to target tissues is regulated by sex hormone-binding globulin (SHBG), a transport protein secreted by liver i.e. specific for androgens. Present study was done to find the association of rs6259 polymorphism with SHBG levels and Poly Cystic Ovary Syndrome in Indian population. Present study was a case control study. 400 subjects were enrolled for the study and serum SHBG levels and D327N polymorphism were measured. The D327N polymorphism (wild-type and variant allele) was detected using PCR-RFLP method (restriction enzyme Bbs-I). PCOS group was found to have significantly lower SHBG levels than healthy controls. There was no significant difference in genotype distribution between PCOS and controls ($ χ^{2} $ = 1.0335, p = 0.59). Significant difference in SHBG levels of PCOS and control group highlights the potential of SHBG as a biomarker for PCOS. However, no significant difference in genotype distribution between PCOS and controls provided an insight that rs6259 polymorphism is not associated with the risk of PCOS and SHBG levels. | ||
| 650 | 4 | |a PCOS |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a SHBG |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Diagnostic marker |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Susceptibility marker |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Polymorphism |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Senwal, Alka |e verfasserin |4 aut | |
| 700 | 1 | |a Nanda, Smiti |e verfasserin |4 aut | |
| 700 | 1 | |a Dang, Amita S. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular biology reports |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1973 |g 46(2019), 2 vom: 04. Feb., Seite 2131-2138 |w (DE-627)SPR015864855 |w (DE-600)1478217-0 |x 1573-4978 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2019 |g number:2 |g day:04 |g month:02 |g pages:2131-2138 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11033-019-04665-2 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 42.13 |q ASE |
| 951 | |a AR | ||
| 952 | |d 46 |j 2019 |e 2 |b 04 |c 02 |h 2131-2138 | ||